Hester Biosciences Hits 52-Week Low, Receives 'Strong Sell' Call from MarketsMOJO

Hester Biosciences, a smallcap pharmaceutical company, has recently hit a 52-week low in its stock price. On March 12, 2024, the company's stock price touched Rs.1351.85, the lowest it has been in the past year. This has led to a 'Strong Sell' call by MarketsMOJO, a leading financial analysis platform.

The stock's performance today has underperformed the sector by -0.55%, indicating a downward trend. In fact, Hester Biosciences has been on a consecutive fall for the last 6 days, with a -5.37% return in this period. This is further reflected in the stock's moving averages, as it is currently trading lower than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the Sensex, Hester Biosciences has had a negative 1-year performance of -21.11%, while the Sensex has shown a positive performance of 24.90%. This highlights the struggles faced by the company in the past year.

Despite these challenges, Hester Biosciences remains a key player in the pharmaceutical industry, with a focus on animal health. The company has a strong portfolio of products and is continuously expanding its reach in both domestic and international markets. With a dedicated team and a commitment to innovation, Hester Biosciences is poised for growth in the future.